SCHEMBL8778150

SCHEMBL8778150

Cc1cc(Cc2cccc(-c3ncc4ccccc4n3)n2)ccc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
POLB P06746 1/20 0.34
STAT3 P40763 1/20 0.34
CTNNB1 P35222 1/20 0.34
TCF7L2 Q9NQB0 1/20 0.34
MPO P05164 1/20 0.33
MBNL1 Q9NR56 1/20 0.33
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
GRIN1 Q05586 1/20 0.32
KCNH2 Q12809 1/20 0.32
GRIN2B Q13224 1/20 0.32
CASR P41180 1/20 0.32
PCSK9 Q8NBP7 1/20 0.32
S1PR3 Q99500 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778211 0.90 CYP1A2 (0.38) CYP1A2LMNAMAPTHTTSMN1; SMN2
SCHEMBL8865272 0.84 USP1 (0.39) TRPM8
SCHEMBL8778292 0.84 CYP1A2 (0.34) CYP1A2LMNAMAPTHTTSMN1; SMN2
SCHEMBL8778044 0.83 CYP2C19 (0.38) CYP1A2LMNAMAPTHTTCYP2C9
SCHEMBL8777762 0.83 USP1 (0.39) CYP1A2LMNAMAPTHTTSMN1; SMN2
SCHEMBL8777888 0.83 SMN1; SMN2 (0.40) CYP1A2LMNAMAPTHTTSMN1; SMN2
SCHEMBL8777914 0.81 KDM4E (0.39) CYP1A2MAPT
SCHEMBL8778144 0.81 USP1 (0.39) CYP1A2LMNAMAPTHTTSMN1; SMN2
SCHEMBL29368748 0.80 CYP1A2 (0.40) CYP1A2SMN1; SMN2KCNH2PCSK9L3MBTL1
SCHEMBL3787262 0.80 CYP1A2 (0.40) CYP1A2SMN1; SMN2KCNH2PCSK9L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES NAT1, NQO2, NOX1 CYP1A2 18/4885LMNA 3612/4885MAPT 3067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.